Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy

Pharmacogenomics

Volumn 12, Issue 3, 2011, Pages 319-325

  Kwan, Patrick ^a   Wong, Virginia ^b   Ng, Ping Wing ^c   Lui, Colin Hiu Tung ^d   Sin, Ngai Chuen ^e   Wong, Ka Sing ^a   Baum, Larry ^f  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d TSEUNG KWAN O HOSPITAL   (Hong Kong)

^e HOSPITAL AUTHORITY   (Hong Kong)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ABCC2; ABCC5; ABCG2; antiepileptic drugs; drug resistance; epilepsy; pharmacogenomics

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 5; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG RESPONSE; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; PHARMACOGENOMICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; EPILEPSY; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79953235784     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.183     Document Type: Article

References (18)

1. Kwan P, Brodie MJ: Potential role of drug transporters In the pathogenesis of medically intractable epilepsy. Epilepsia 46, 224-235 (2005). (Pubitemid 40194666)
2. Kimchi-Sarfaty C, OhJM, Kim L-W, et al. A 'silent' polymorphism in the MDRl gene changes substrate specificity. Science 315, 525-528 (2007). (Pubitemid 46175758)
3. Haerian BS, Roslan H, RaymondAA et al. ABCBl C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure 19,339-346(2010).
4. Sisodiya SM, Martinian L, Scheffer GL et al. Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia 44, 1388-1396 (2003). (Pubitemid 37385846)
5. Aronica E, Gorter JA, Redeker S et al.: Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia 46, 849-857 (2003).
6. Kutoba H, Ishihara H, Langmann T et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res. 68, 213-228(2006).
7. Potschka H, Fedrowitz M, Loscher W: Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. Pharmacol. Exp. Ther. 306, 124-131 (2003). (Pubitemid 36734365)
8. Seo T, Ishitsu T, Oniki K, Abe T, Shuto T, Nakagawa K: ABCC2 haplotype is not associated with drug-resistant epilepsy. Pharm. Pharmacol. 60, 631-635 (2008). (Pubitemid 351589051)
9. > and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy. Epilepsy Res. 84, 86-90 (2009).
10. UferM, Mosyagin I, Muhle H et al.: Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy. Pharmacogenet. Genomics 19, 353-362 (2009).
11. Kwan P, Baum L, Wong V et al.: Association between ABCBl C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav. 11, 112-117(2007). (Pubitemid 47087203)
12. Kwan P, Arzimanoglou A, Berg AT et al.: Definition of drug-resistant epilepsy Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51, 1069-1077 (2010).
13. Kwan P, Wong V, Ng PW et al.: Gene-wide tagging study of association between ABCBl polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics 10,723-732 (2009).
14. Sanchez MB, Herranz JL, Leno C et al. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure 19, 93-101 (2010).
15. Bakes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Loscher W: Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52, 333-346(2007). (Pubitemid 46123353)
16. Potschka H, Fedrowitz M, Loscher W: Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in 5CC2/MRP2-deficient TR-rats. Epilepsia 44, 1479-1486 (2003). (Pubitemid 38020180)
17. Luna-Tortos C, Fedrowitz M, Loscher W: Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRPl, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology 58, 1019-1032 (2010).
18. Cerveny L, Pavek P, Malakova J, Staud F, Fendrich Z: Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia 47, 461-468 (2006). (Pubitemid 43351546)